Cbd Life Valuation
| CBDL Stock | USD 0.0005 0.0001 25.00% |
Cbd Life seems to be overvalued based on Macroaxis valuation methodology. Our model approximates the value of Cbd Life Sciences from analyzing the firm fundamentals such as return on equity of -3.89, and Operating Margin of (23.29) % as well as examining its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Cbd Life's price fluctuation is out of control at this time. Calculation of the real value of Cbd Life Sciences is based on 3 months time horizon. Increasing Cbd Life's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Cbd pink sheet is determined by what a typical buyer is willing to pay for full or partial control of Cbd Life Sciences. Since Cbd Life is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Cbd Pink Sheet. However, Cbd Life's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 5.0E-4 | Real 3.84E-4 | Hype 2.44E-4 | Naive 2.02E-4 |
The intrinsic value of Cbd Life's stock can be calculated using various methods such as discounted cash flow or dividend analysis. That value may differ from its market price, which is determined by factors such as investor sentiment, market trends, headlines, and other external factors that may influence Cbd Life's stock price.
Estimating the potential upside or downside of Cbd Life Sciences helps investors to forecast how Cbd pink sheet's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Cbd Life more accurately as focusing exclusively on Cbd Life's fundamentals will not take into account other important factors: Cbd Life Total Value Analysis
Cbd Life Sciences is currently forecasted to have valuation of 51.93 K with market capitalization of 35.85 K, debt of 0, and cash on hands of 303.09 K. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Cbd Life fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
51.93 K | 35.85 K | 0 | 303.09 K |
Cbd Life Investor Information
The company last dividend was issued on the 5th of February 2019. Cbd Life Sciences had 1:100 split on the 5th of February 2019. Based on the measurements of operating efficiency obtained from Cbd Life's historical financial statements, Cbd Life Sciences is not in a good financial situation at this time. It has a very high probability of going through financial hardship in January.Cbd Life Asset Utilization
The concept of asset utilization usually refers to the revenue earned for every dollar of assets a company currently reports. The latest return on assets of Cbd suggests not a very effective usage of assets in December.Cbd Life Profitability Analysis
The company reported the previous year's revenue of 138.19 K. Net Loss for the year was (6.14 M) with profit before overhead, payroll, taxes, and interest of 27.43 K.About Cbd Life Valuation
We use absolute and relative valuation methodologies to arrive at the intrinsic value of Cbd Life Sciences. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of Cbd Life Sciences based exclusively on its fundamental and basic technical indicators. By analyzing Cbd Life's financials, quarterly and monthly indicators, and their related drivers, we attempt to find the most accurate representation of Cbd Life's intrinsic value. As compared to an absolute model, our relative valuation model uses a comparative analysis of Cbd Life. We calculate exposure to Cbd Life's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Cbd Life's related companies.CBD Life Sciences Inc. engages in the development and marketing a line of cannabidiol based organic products. Its cannabidiol based organic products include hemp drops, massage oils, recovery pain relief creams, anxiety and sleep solutions supplements, edibles, and a line of pet products. Cbd Life operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 4 people.
8 Steps to conduct Cbd Life's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Cbd Life's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Cbd Life's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Cbd Life's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Cbd Life's revenue streams: Identify Cbd Life's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Cbd Life's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Cbd Life's growth potential: Evaluate Cbd Life's management, business model, and growth potential.
- Determine Cbd Life's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Cbd Life's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Cbd Life Growth Indicators
Investing in growth stocks can be very risky. If the company such as Cbd Life does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Retained Earnings | -13.6 M | |
| Quarterly Revenue Growth Y O Y | 2.428 |
Other Information on Investing in Cbd Pink Sheet
Cbd Life financial ratios help investors to determine whether Cbd Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Cbd with respect to the benefits of owning Cbd Life security.